Page 117

117

Screening measure is limited to screening only and does not assess appropriate and timely follow-up after abnormal results from an initial screening. This measure concept will be developed and tested using the ECDS-reporting method that leverages multiple data sources (i.e., claims, electronic health records, health information exchanges, registries). The measure is being targeted for inclusion in HEDIS starting with the 2027 measurement year. There was mixed feedback on this potential new HEDIS measure although more than half of commenters supported further work in this area taking into consideration the variety of FDA-authorized screening technologies, the window for follow-up, and testing across a variety of EHR vendors. Some commenters suggested that I-SNP enrollees be included. We have shared these comments with NCQA for their review. End-Stage Renal Disease (ESRD) (Part C). NCQA has completed preliminary analyses to identify MA members with chronic kidney disease (CKD) stage 4 or with ESRD as part of a feasibility assessment of a future measure focused on ESRD in MA. NCQA is obtaining feedback on potential measure concepts from a newly convened kidney expert working group. A measure is planned for measurement year 2027. Although a few commenters expressed support for developing measures related to ESRD, most commenters requested more information. There was some interest in focusing measure development on early intervention and prevention. We have shared this feedback with NCQA for their consideration. Person-Centered Outcomes (Part C). NCQA is developing three measures focused on identifying, measuring, and tracking goals over time. The person-centered outcome measures incorporate what matters most (person-centered outcome goals) to individuals with complex care needs into care planning and quality measurement. The first measure, Goal Identification, assesses whether a person-centered outcome goal was identified, documented using either a patient-reported outcome measure (PROM) or goal attainment scaling (GAS), and an action plan developed. The second measure, Goal Follow-up, assesses if the person-centered outcome goal was followed up on within two weeks to six months of when the goal and PROM/GAS were identified. The third measure, Goal Achievement, assesses whether the person-centered outcome goal was achieved. NCQA began measure testing in fall 2024 for a potential SNP only measure to include in HEDIS. The measures are planned for the 2027 measurement year at the earliest. We welcomed comments on this measurement concept and whether SNP-specific measures should be considered given our goal of trying to simplify and refocus the Star Ratings measure set. There was mixed reaction to this measurement concept and concerns raised about the additional burden of this type of measure, as well as whether this type of measure should be limited to SNP enrollees. We have shared this feedback received with NCQA. Respiratory Syncytial Virus (RSV) Immunization Indicator for Adult Immunization Status (Part C). As guidelines continue to develop around RSV vaccination for adults, NCQA is assessing and determining the appropriateness of incorporating this vaccine indicator in the Adult Immunization Status measure. Any potential updates would likely be included no earlier